Research reviewThe Neurocognitive Enhancement of Surgeons: An Ethical Perspective
Introduction
Neurocognitive enhancement, the practice of improving the neurological function of individuals who are disease free, has been the subject of recent media, political, and ethical interest [1, 2, 3]. Nonpharmacological methods, such as Transcranial Magnetic Stimulation, Brain–Machine interfaces, and neurosurgical implantation of devices and tissue are all at early stages of development, with most research still focused on their role alleviating pathology [4, 5, 6, 7]. Psychopharmacological enhancement is further developed and has undergone more extensive evaluation. Prescription medications such as donepezil (Aricept; Eisai, Tokyo, Japan), modafinil (Provigil; Cephalon Inc., Frazer, PA), methylphenidate (Ritalin; Novartis, Bern, Switzerland), and bromocriptine (Parlodel; Novartis), originally developed to treat neurological and psychiatric illnesses, are being increasingly investigated for their potential to enhance memory, cognition, and executive function in healthy individuals. While this may sound radical, for many healthy people enhancing normal neurocognitive function is already a fact of life. In the United States the proportion of boys taking methylphenidate is at epidemic levels, exceeding the highest estimated prevalence of Attention Deficit Hyperactivity Disorder [8], which suggests that normal childhood high spirits are being dampened by pharmacological means to enhance the educational experience. This is not limited to schools; an estimated 16% of students at some United States universities take prescription medication as study aids [9]. Finally, nonprescription supplements are being increasingly used in an attempt to improve memory, cognition, and ward off fatigue. Ginkgo biloba, a Chinese herbal medicine, is now a billion dollar industry in the United States alone [10], despite only limited effects on cognition [11]. The field of neurocognitive enhancement is already here and is growing.
The vast ethical implications of this developing field have been partly addressed within the literature, but from the view of prescriber [12] or society as a whole [13]; no one has considered the implications of neurocognitive enhancement for current surgical practice. This article outlines why surgeons may soon consider using prescription medications, or technological interventions, originally designed to treat neuropsychological pathologies, to enhance their performance. We focus predominantly on drugs, as the evidence suggests this is the more imminent and likely form of neurocognitive enhancement that surgeons may consider, and address the resulting significant ethical implications of these actions. We do not seek to support nor denounce the potential for neurocognitive enhancement in surgeons, simply to outline the ethical debate that now needs to take place.
Section snippets
What Are the Potential Targets for Neurocognitive Enhancement in Surgeons?
There is an increasing array of pharmacological agents that have been demonstrated to affect “Executive Function,” the abilities that enable flexible, task-appropriate responses in the face of irrelevant competing inputs or more habitual but inappropriate response patterns [13]. This includes cognition, working memory, and attention, important functions for surgeons. Methylphenidate (Ritalin) is already prescribed to sufferers of attention-deficit hyperactivity disorder (ADHD) to improve
Ethical Considerations
We explore the ethical implications of neurocognitive enhancement of surgeons by considering the key areas summarized in Fig. 1.
Safety
When considering the potential risks involved in neurocognitive enhancement, it is essential to define the scale of intervention being discussed. While anything may become possible in the future, we find it hard to imagine surgeons considering invasive neurosurgical procedures to insert neural implants, just to gain a slight increase in capability. However, taking medication, either regularly or when needed, seems more plausible. We are aware that all medicines have side effects, from minor
Freedom of Choice
Both the United Kingdom and the United States are strongly libertarian, and many people will believe that if individuals are given adequate information about effects, and potential side effects, they should be free to make their own decisions. Should surgeons not be free to take medication because they feel it improves their technical and cognitive performance, even if they put themselves at a slight risk of adverse events? If we demonstrably improve a surgeon's performance, and the surgeon is
Character, Individuality, and Personhood
Within medical society, there is a “no pain, no gain” belief system, a belief that toil, struggle, and sacrifice are necessary for progression, and that hard work throughout the undergraduate and postgraduate years builds character. The ethical argument that follows is that “unnatural interventions” that ease the acquisition and retention of skill and knowledge undermine good character. Improving without working is cheating, and cheating cheapens us all [44]. These are valid concerns but in
Distributive Justice
If neurocognitive enhancers are not fairly distributed, they will provide an unfair advantage only for the rich or well connected. This may be particularly true at medical schools, where relatively wealthy undergraduates already tend to have certain advantages over their poorer colleagues; are we to add to these by making neurocognitive enhancement a preserve of the wealthy? Conversely, our society is full of inequality already and it may be no more grounds for prohibiting access to enhancement
Coercion and Regulation
If robust evidence demonstrating significant performance improvement following neurocognitive enhancement was forthcoming, surgeons may feel pressure from society to participate. It may go against certain medical principles to envisage coercion of an individual to take any drug, but this is not without similar precedents. Many societies strongly encourage participation in vaccination programs, on the advice of its physicians. Likewise it pressures (or forces via legislation) its clinicians to
Conclusions
The ethical debate surrounding neurocognitive enhancement of surgeons is emotive and multifaceted. Research evaluating the influence of novel stimulants on clinical performance has commenced and is likely to continue and expand. Patients are becoming increasingly aware of the performance variations between surgeons, and in years to come they may ask what forms of neurocognitive enhancement we do or do not practice, and on what evidence we make our choices. As the pharmaceutical industry forges
References (49)
Treatment, enhancement, and the ethics of neurotherapeutics
Brain Cogn
(2002)The quest for a smart pill
Sci Am
(2003)- et al.
Methylphenidate treatment
Pediatr Neurol
(2002) - et al.
Cognitive effects of modafinil in student volunteers may depend on IQ
Pharmacol Biochem Behav
(2005) - et al.
Effect of sleep deprivation on surgeons' dexterity on laparoscopy simulator
Lancet
(1998) - et al.
Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals
Eur J Pharmacol
(1990) - et al.
Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice
Eur Neuropsychopharmacol
(1995) - et al.
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: A review
Pharmacol Biochem Behav
(2001) ‘Smart drugs’: do they work?Are they ethical? Will they be legal?
Nat Rev Neurosci
(2002)Emerging ethical issues in neuroscience
Nat Neurosci
(2002)
Transcranial magnetic stimulation in neurorehabilitation
Acta Neurochir Suppl
Brain-computer interfaces: Communication and restoration of movement in paralysis
J Physiol
Neural prostheses and biomedical microsystems in neurological rehabilitation
Acta Neurochir Suppl
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease
J Med Ethics
The run on RitalinAttention deficit disorder and stimulant treatment in the 1990s
Hastings Cent Rep
Student perceptions of methylphenidate abuse at a public liberal arts college
J Am Coll Health
Ginkgo for memory enhancement: A randomized controlled trial
JAMA
Cosmetic neurology: The controversy over enhancing movement, mentation, and mood
Neurology
Neurocognitive enhancement: what can we do and what should we do?
Nat Rev Neurosci
Attention deficit disorder in adults
Ann Clin Psychiatry
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
J Neurosci
Facilitation of working memory by a D2 receptor agonist in human subjects
J Cogn Neurosci
Donepezil and flight simulator performance: Effects on retention of complex skills
Neurology
Effects of acute modafinil ingestion on exercise time to exhaustion
Med Sci Sports Exerc
Cited by (29)
Structured cues or modafinil for fatigue amelioration in clinicians? A double-blind, randomized controlled trial of critical clinical information recall in fatigued clinicians
2016, Surgery (United States)Citation Excerpt :Although there is freedom of choice in a libertarian society, the potential benefits of cognitive enhancement must be considered carefully while minimizing risk to all. Whilst it is not the authors recommendation to administer neurocognitive enhancement, an ethical framework needs to be developed within which forthcoming developments can be addressed.61 Instead of depending on free recall of clinical data or neuropharmacology with its attendant ethical implications,61 checklist systems decrease error-related effects through recognition of specific aspects of care provision, thus improving safety.28
Public Opinion on Cognitive Enhancement Varies across Different Situations
2020, AJOB NeuroscienceComparison of philosophical concerns between professionals and the public regarding two psychiatric treatments
2018, AJOB Empirical BioethicsEmotional and cognitive overload: The dark side of information technology
2018, Emotional and Cognitive Overload: The Dark Side of Information TechnologyUse of cognitive enhancers among medical students in Lithuania
2016, NAD Nordic Studies on Alcohol and Drugs